1,824
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren’s syndrome

ORCID Icon, , , &
Pages 333-343 | Received 21 Nov 2019, Accepted 09 Jul 2020, Published online: 20 Jul 2020

References

  • Franceschini F , Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity. 2005;38(1):55–63.
  • Volchenkov R , Jonsson R , Appel S. Anti-Ro and anti-La autoantibody profiling in Norwegian patients with primary Sjögren’s syndrome using luciferase immunoprecipitation systems (LIPS)). Scand J Rheumatol. 2012;41(4):314–315.
  • Gordon TP , Bolstad AI , Rischmueller M , et al. Autoantibodies in primary Sjögren’s syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity. 2001;34(2):123–132.
  • Aqrawi LA , Skarstein K , Oijordsbakken G , et al. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren’s syndrome. Clin Exp Immunol. 2013;172(2):228–237.
  • Jonsson R , Bolstad AI , Brokstad KA , et al. Sjögren’s syndrome-a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci. 2007;1108:433–447.
  • Jonsson R , Vogelsang P , Volchenkov R , et al. The complexity of Sjögren’s syndrome: novel aspects on pathogenesis. Immunol Lett. 2011;141(1):1–9.
  • Ramos-Casals M , Brito-Zeron P , Siso-Almirall A , et al. Topical and systemic medications for the treatment of primary Sjögren’s syndrome. Nat Rev Rheumatol. 2012;8(7):399–411.
  • Pullerits R , Jonsson IM , Verdrengh M , et al. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum. 2003;48(6):1693–1700.
  • Chisholm DM , Mason DK. Labial salivary gland biopsy in Sjögren’s disease. J Clin Pathol. 1968;21(5):656–660.
  • Daniels TE , Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjogren’s syndrome. Arthritis Rheum. 1994;37(6):869–877.
  • Giovelli RA , Santos MC , Serrano EV , et al. Clinical characteristics and biopsy accuracy in suspected cases of Sjögren’s syndrome referred to labial salivary gland biopsy. BMC Musculoskelet Disord. 2015;16:30
  • Skopouli FN , Li L , Boumba D , et al. Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren’s syndrome. Clin Exp Rheumatol. 1998;16:63–65.
  • Skarstein K , Aqrawi LA , Oijordsbakken G , et al. Adipose tissue is prominent in salivary glands of Sjögren’s syndrome patients and appears to influence the microenvironment in these organs. Autoimmunity. 2016;49(5):338–346.
  • Aqrawi LA , Jensen JL , Oijordsbakken G , et al. Signalling pathways identified in salivary glands from primary Sjögren’s syndrome patients reveal enhanced adipose tissue development. Autoimmunity. 2018;51(3):135–146.
  • Giusti L , Baldini C , Bazzichi L , et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases-the example of Sjögren’s syndrome. Proteomics. 2007;7(10):1634–1643.
  • Baldini C , Giusti L , Ciregia F , et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren’s syndrome from secondary Sjögren’s syndrome and other sicca syndromes. Arthritis Res Ther. 2011;13(6):R194.
  • Giusti L , Baldini C , Bazzichi L , et al. Proteomic diagnosis of Sjögren’s syndrome. Expert Rev Proteomics. 2007;4(6):757–767.
  • Ryu OH , Atkinson JC , Hoehn GT , et al. Identification of parotid salivary biomarkers in Sjogren’s syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford). 2006;45(9):1077–1086.
  • Peluso G , De Santis M , Inzitari R , et al. Proteomic study of salivary peptides and proteins in patients with Sjögren’s syndrome before and after pilocarpine treatment. Arthritis Rheum. 2007;56(7):2216–2222.
  • Hu S , Wang J , Meijer J , et al. Salivary proteomic and genomic biomarkers for primary Sjogren’s syndrome. Arthritis Rheum. 2007;56(11):3588–3600.
  • Hu S , Vissink A , Arellano M , et al. Identification of autoantibody biomarkers for primary Sjögren’s syndrome using protein microarrays. Proteomics. 2011;11(8):1499–1507.
  • Fleissig Y , Deutsch O , Reichenberg E , et al. Different proteomic protein patterns in saliva of Sjögren’s syndrome patients. Oral Dis. 2009;15(1):61–68.
  • Delaleu N , Mydel P , Kwee I , et al. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren’s syndrome. Arthritis & Rheumatology. 2015;67(4):1084–1095.
  • Denny P , Hagen FK , Hardt M , et al. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res. 2008;7(5):1994–2006.
  • Tomosugi N , Kitagawa K , Takahashi N , et al. Diagnostic potential of tear proteomic patterns in Sjögren’s syndrome. J Proteome Res. 2005;4(3):820–825.
  • Aqrawi LA , Galtung HK , Vestad B , et al. Identification of potential saliva and tear biomarkers in primary Sjogren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis. Arthritis Res Ther. 2017;19(1):14.
  • Ambatipudi KS , Swatkoski S , Moresco JJ , et al. Quantitative proteomics of parotid saliva in primary Sjögren’s syndrome. Proteomics. 2012;12(19–20):3113–3120.
  • Aqrawi LA , Chen X , Jensen JL , et al. Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjogren’s syndrome. PloS One. 2018;13(10):e0205762.
  • Aqrawi LA , Galtung HK , Guerreiro EM , et al. Proteomic and histopathological characterisation of sicca subjects and primary Sjogren’s syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers. Arthritis Res. Ther. 2019;21(1):181.
  • Pawar RD , Goilav B , Xia Y , et al. Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin. Clin Immunol. 2014;154(1):49–65.
  • Li H , Feng D , Cai Y , et al. Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and neutrophil extracellular traps. Hepatology. 2018;68(4):1604–1620.
  • Ohlsson S , Wieslander J , Segelmark M. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin Exp Immunol. 2003;131(3):528–535.
  • Muthas D , Reznichenko A , Balendran CA , et al. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scand J Gastroenterol. 2017;52(2):125–135.
  • Jonsson N , Gille-Johnson P , Martling CR , et al. Performance of plasma measurement of neutrophil gelatinase-associated lipocalin as a biomarker of bacterial infections in the intensive care unit. J Crit Care. 2019;53:264–270.
  • Da Y , Akalya K , Murali T , et al. Serial quantification of urinary protein biomarkers to predict drug-induced acute kidney injury. CDM. 2019;20(8):656–664.
  • Marko L , Park JK , Henke N , et al. B-cell lymphoma/leukemia 10 (Bcl10) and angiotensin II-induced kidney injury. Cardiovasc Res. 2019.
  • Woo JS , Kim KM , Kang JS , et al. Expression of neutrophil gelatinase-associated lipocalin in human salivary glands. The Annals of otology . Ann. Otol. Rhinol. Laryngol. 2007;116(8):599–603.
  • Vitali C , Bombardieri S , Jonsson R , et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group . Ann Rheum Dis. 2002;61(6):554–558.
  • Rasmussen A , Ice JA , Li H , et al. Comparison of the American-European Consensus Group Sjogren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis. 2014;73(1):31–38.
  • Shiboski SC , Shiboski CH , Criswell L , et al. American College of Rheumatology classification criteria for Sjogren’s syndrome: a data-driven, expert consensus approach in the Sjogren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res. 2012;64(4):475–487.
  • Enger TB , Aure MH , Jensen JL , et al. Calcium signaling and cell volume regulation are altered in Sjögren’s Syndrome. Acta Odontol Scand. 2014;72(7):549–556.
  • Isaksen K , Jonsson R , Omdal R. Anti-CD20 treatment in primary Sjögren’s syndrome. Scand J Immunol. 2008;68(6):554–564.
  • Cornec D , Devauchelle-Pensec V , Tobon GJ , et al. B cells in Sjögren’s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun. 2012;39(3):161–167.
  • Nicaise C , Weichselbaum L , Schandene L , et al. Phagocyte-specific S100A8/A9 is upregulated in primary Sjogren’s syndrome and triggers the secretion of pro-inflammatory cytokines in vitro. Clin Exp Rheumatol. 2017;35:129–136.
  • Szyszko EA , Brokstad KA , Oijordsbakken G , et al. Salivary glands of primary Sjögren’s syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther. 2011;13(1):R2.